Thanks for your stock whoever you are. Some investors still place little credibility to partnerships despite this more formal guidance:
Even the most tardy/disingenuous of executives should finally be able to get a partnership(s) for PAR over the line with FDA clearance of their Phase III now complete. 1H 2025 will surely see some developments of partnership news (and a corresponding ramp up in the share price on prospects of) if not a partnership completed - these things do take some time, as those regularly following the bio-tech collaboration space can attest.
Pleasantly surprised to be able to be buying back stock here after the raise and rally, but gladly doing so. Didn't think many insto's/soph's would sell out much below $0.48 for a quick profit, so suspect this is beleaguered retail getting out whilst they can. Nothing likes snatching defeat from the jaws of coming victory.
(20min delay)